Migraine headache in children

Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007 Apr;92(2):ep50-5. Abstract

Fisher E, Law E, Dudeney J, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2018 Sep 29;(9):CD003968.Full text  Abstract

Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016 Apr 19;(4):CD005220.Full text  Abstract

Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):487-99.Full text  Abstract

Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):500-9.Full text  Abstract

1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2013 Jul;33(9):629-808.Full text  Abstract

2. Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007 Apr;92(2):ep50-5. Abstract

3. Goadsby PJ. To scan or not to scan in headache. BMJ. 2004 Aug 28;329(7464):469-70.Full text  Abstract

4. Migraine. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia, PA: Saunders; 2000:1832-34.

5. Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991 Nov 15;134(10):1111-20. Abstract

6. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA. 1992 Jan 1;267(1):64-9. Abstract

7. Mortimer MJ, Kay J, Gawkrodger DJ, et al. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache. 1993 Sep;33(8):427-31. Abstract

8. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994 Jun;34(6):319-28. Abstract

9. Bille BS. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Paediatr Suppl. 1962 May;136:1-151. Abstract

10. Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache. 1977 Sep;17(4):173-80. Abstract

11. Evers S. Drug treatment of migraine in children. A comparative review. Paediatr Drugs. 1999 Jan-Mar;1(1):7-18. Abstract

12. Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989 Apr 21;261(15):2211-6. Abstract

13. Barnes N, Millman G, James E. Migraine headache in children. Clin Evid. 2006 Jun;(15):469-75. Abstract

14. Bussone G. Pathophysiology of migraine. Neurol Sci. 2004 Oct;25(suppl 3):S239-41. Abstract

15. Ferrari MD. Migraine. Lancet. 1998 Apr 4;351(9108):1043-51. Abstract

16. Stewart WF, Staffa J, Lipton RB, et al. Familial risk of migraine: a population-based study. Ann Neurol. 1997 Feb;41(2):166-72. Abstract

17. Rothner AD. Childhood migraine: clinical features, classifications and diagnostic criteria. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:54-65.

18. Hamalainen ML. Medical and dietary management of headache and migraine. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:136-48.

19. Passchier J, Orlebeke JF. Headaches and stress in schoolchildren: an epidemiological study. Cephalalgia. 1985 Sep;5(3):167-76. Abstract

20. Amery WK, Vandenbergh V. What can precipitating factors teach us about the pathogenesis of migraine? Headache. 1987 Mar;27(3):146-50. Abstract

21. Barnes NP, Jayawant S. Migraine. Arch Dis Child Educ Pract Ed. 2005;90:ep53-7.Full text

22. Wilne S, Koller K, Collier J, et al. The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour. Arch Dis Child. 2010 Jul;95(7):534-9. Abstract

23. American College of Radiology. ACR appropriateness criteria: headache - child. 2017 [internet publication].Full text

24. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.Full text  Abstract

25. National Institute for Health and Care Excellence. Headaches in over 12s: diagnosis and management. November 2015 [internet publication].Full text

26. Bonfert M, Straube A, Schroeder AS, et al. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013 Feb;44(1):3-19. Abstract

27. Fisher E, Law E, Dudeney J, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2018 Sep 29;(9):CD003968.Full text  Abstract

28. Bruijn J, Locher H, Passchier J, et al. Psychopathology in children and adolescents with migraine in clinical studies: a systematic review. Pediatrics. 2010 Aug;126(2):323-32. Abstract

29. Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J Paediatr Child Health. 2008 Jan;44(1-2):3-9. Abstract

30. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016 Apr 19;(4):CD005220.Full text  Abstract

31. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):487-99.Full text  Abstract

32. US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. April 2017 [internet publication].Full text

33. Medicines and Healthcare Products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. 2013 June;6(11):S1.Full text

34. European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication].Full text

35. Brenner M, Lewis D. The treatment of migraine headaches in children and adolescents. J Pediatr Pharmacol Ther. 2008 Jan;13(1):17-24.Full text  Abstract

36. Damen L, Bruijn JK, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005 Aug;116(2):e295-302.Full text  Abstract

37. Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010 Dec 1;12(6):379-89. Abstract

38. Lewis DW, Winner P, Hershey AD, et al; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007 Aug;120(2):390-6. Abstract

39. Winner P, Lewis D, Visser WH, et al; Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002 Jan;42(1):49-55. Abstract

40. Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008 May;24(5):321-30. Abstract

41. Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012 Jul;32(10):750-65. Abstract

42. Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008 Oct;48(9):1326-36. Abstract

43. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J Headache Pain. 2006 Apr;7(2):95-7.Full text  Abstract

44. Berenson F, Vasconcellos E, Pakalnis A, et al. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache. 2010 May;50(5):795-807. Abstract

45. Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012 Jun;129(6):e1411-20. Abstract

46. Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother. 2007 Jul;41(7):1181-90. Abstract

47. Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):500-9.Full text  Abstract

48. El-Chammas K, Keyes J, Thompson N, et al. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr. 2013 Mar 1;167(3):250-8.Full text  Abstract

49. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. March 2018 [internet publication].Full text

50. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia. 1985;5(suppl 2):145-148. Abstract

51. Sorge F, De Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia. 1988;8:1-6. Abstract

52. Pearce JM. Migraine. In: Weatherall DJ, Ledingham JG, Warrell DA, eds. Oxford textbook of medicine. Oxford: Oxford University Press; 1996:4024-6.

53. McGrath PJ, Humphreys P, Keene D, et al. The efficacy of a self-administered treatment for adolescent migraine. Pain. 1992 Jun;49(3):321-4. Abstract

54. Blau JN, Thavapalan M. Preventing migraine: a study of precipitating factors. Headache. 1988 Aug;28(7):481-3. Abstract